BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4522153)

  • 1. Trisomy 8 in acute myeloblastic leukemia and sideroachrestic anemia.
    Jonasson J; Gahrton G; Lindsten J; Simonsson-Lindemalm C; Zech L
    Blood; 1974 Apr; 43(4):557-63. PubMed ID: 4522153
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridoxal-5-phosphate-resistant sideroblastic anaemia with trisomy 8 mosaicism in the bone marrow.
    Penchas S; Zlotnick A; Cohen R; Cohen MM
    Acta Haematol; 1977; 57(6):354-8. PubMed ID: 407766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of primary acquired sideroblastic anemia with pyridoxal-5-phosphate. Recent experience].
    Hansen OP; Drivsholm A; Hardt F
    Ugeskr Laeger; 1976 Nov; 138(48):3035-8. PubMed ID: 982656
    [No Abstract]   [Full Text] [Related]  

  • 4. Serial in vitro marrow culture in acute myelocytic leukemia.
    Bull JM; Duttera MJ; Stashick ED; Northup J; Henderson E; Carbone PP
    Blood; 1973 Nov; 42(5):679-86. PubMed ID: 4518061
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary acquired sideroblastic anaemia: response to treatment with pyridoxal-5-phosphate.
    Mason DY; Emerson PM
    Br Med J; 1973 Feb; 1(5850):389-90. PubMed ID: 4691061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the pathogenesis of alcohol-induced sideroblastic bone-marrow abnormalities.
    Hines JD; Cowan DH
    N Engl J Med; 1970 Aug; 283(9):441-6. PubMed ID: 5434110
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W; Resegotti L; Rossi M; Infelise V
    Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic refractory sideroachrestic anemia (IRSA) progressing to acute mixed lymphoblastic-myelomonoblastic leukemia. Case report and review of the literature.
    Hehlmann R; Zönnchen B; Thiel E; Walther B
    Blut; 1983 Jan; 46(1):11-21. PubMed ID: 6571788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 10. [Difficulties of remission induction treatment of acute myeloblastic leukemia].
    Fière D; Bryon PA; Martin C; Revol L
    Sem Hop; 1974 May; 50(25):1691-4. PubMed ID: 4369538
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
    Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
    Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
    [No Abstract]   [Full Text] [Related]  

  • 12. Sideroblastic anaemia and jejunal diverticulosis.
    Child JA; Mallinson CN
    Guys Hosp Rep; 1973; 122(3-4):245-57. PubMed ID: 4218184
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary acquired sideroblastic anaemia associated with chronic lymphocytic leukaemia.
    Papayannis AG; Stathakis NE; Kyrkoy K; Panani A; Gardikas C
    Br J Haematol; 1974 Sep; 28(1):125-9. PubMed ID: 4415196
    [No Abstract]   [Full Text] [Related]  

  • 14. Trisomy 14 in acute myeloid leukemia with ringed sideroblasts.
    Wong KF
    Cancer Genet Cytogenet; 2004 Jul; 152(2):175-6. PubMed ID: 15262443
    [No Abstract]   [Full Text] [Related]  

  • 15. Unusual anaemias of old age.
    Lancet; 1973 Mar; 1(7803):589-90. PubMed ID: 4120651
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow delta-aminolaevulinate synthase deficiency in a female with congenital sideroblastic anemia.
    Buchanan GR; Bottomley SS; Nitschke R
    Blood; 1980 Jan; 55(1):109-15. PubMed ID: 7350930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic refractory anemia with hyperplastic bone marrow].
    Pöttgen W
    Dtsch Med Wochenschr; 1971 Oct; 96(42):1633-9. PubMed ID: 5291300
    [No Abstract]   [Full Text] [Related]  

  • 18. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Eur J Cancer (1965); 1974 Jul; 10(7):413-8. PubMed ID: 4532961
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromosomes and causation of human cancer and leukemia. IX. Prognostic and therapeutic value of chromosomal findings in acute myeloblastic leukemia.
    Sakurai M; Sandberg AA
    Cancer; 1974 Jun; 33(6):1548-57. PubMed ID: 4525996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.